Back |
home / stock / sabs / sabs message board
Subject | By | Source | When |
---|---|---|---|
Historic short interest: | XenaLives | investorshub | 11/24/2021 10:02:36 PM |
Monoclonal antibodies vs polyclonal antibodies: | XenaLives | investorshub | 10/30/2021 11:36:53 AM |
Video on home page - not youtube so | XenaLives | investorshub | 10/30/2021 11:22:52 AM |
Big Cypress Acquisition Corp Announces Special Meeting of | XenaLives | investorshub | 10/30/2021 11:15:45 AM |
$SABS: Engineered Immunity | XenaLives | investorshub | 10/30/2021 11:10:57 AM |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc. Company Name:
SABS Stock Symbol:
NASDAQ Market:
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS) (the "Company" or "SAB"), a clinical-stage biopharmaceutical company w...
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progres...
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...